search
Back to results

Characterisation of Cortical Vestibular Evoked Potentials (C-VEPs)

Primary Purpose

Vestibular Neuronitis

Status
Unknown status
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
cortical vestibular evoked potentials (CVEPs)
Sponsored by
Sheffield Teaching Hospitals NHS Foundation Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Vestibular Neuronitis focused on measuring partial vestibular deficit, cortical vestibular evoked potential

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Vestibular deficit Group:

    1. Over 18 years of age
    2. Can provide informed consent
    3. Deemed to have an otoneurological cause for their symptoms (true vertigo, room spinning even when head is still)
    4. No middle ear pathology

NORMATIVE GROUP:

  1. Over 18 years of age
  2. Can provide informed consent
  3. No previous otoneurological history

Exclusion Criteria:

  • VESTIBULAR DEFICIT GROUP PATIENTS

    1. Participants under the age of 18
    2. Participants unable to provide informed consent
    3. Patients not deemed to have an otoneurological cause for their symptoms
    4. Patients with middle ear pathology

NORMATIVE GROUP:

  1. Previous history of problems with hearing and or balance
  2. Participants under the age of 18
  3. Participants unable to provide informed consent

Sites / Locations

  • Sheffield Teaching Hospitals NHS TrustRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

vestibular deficit

otologically normal controll

Arm Description

Initial clinical assessment including otoneurological examination, pure tone audiometry, tympanometry vestibular screening tests and Magnetic Resonance Imaging as clinically indicated. The cortical vestibular evoked potentials will add approximately add an extra 30 minutes to the test sequence but is minimally invasive and will not cause any pain or discomfort. It will be conducted on both the affected and non-affected ears.

Normative data will be collected from 36 normal ears from subjects that have no history of audiovestibular symptoms and are not being investigated for any balance disorders. The cortical vestibular evoked potentials will be recorded from both ears

Outcomes

Primary Outcome Measures

The degree of change of cortical vestibular evoked potential measured by amplitude (in microvolts)

Secondary Outcome Measures

The time interval between the stimulation and response (latency) of cortical vestibular evoked potential

Full Information

First Posted
May 28, 2015
Last Updated
June 2, 2015
Sponsor
Sheffield Teaching Hospitals NHS Foundation Trust
search

1. Study Identification

Unique Protocol Identification Number
NCT02463695
Brief Title
Characterisation of Cortical Vestibular Evoked Potentials (C-VEPs)
Official Title
Characterisation of Cortical Vestibular Evoked Potentials (C-VEPs): A Comparative Study of Normal Ears Versus Those With Vestibular Deficits
Study Type
Interventional

2. Study Status

Record Verification Date
June 2015
Overall Recruitment Status
Unknown status
Study Start Date
October 2014 (undefined)
Primary Completion Date
August 2015 (Anticipated)
Study Completion Date
August 2015 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Sheffield Teaching Hospitals NHS Foundation Trust

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The pathophysiology of vertigo is complex and usually requires specialist involvement. During the diagnostic process, patients commonly undergo tests which assess the integrity of the gaze and posture stabilisation mechanisms involving the inner ear (vestibular system), the visual systems and the subconscious neural pathways that interconnect them. Whilst these tests are useful they fail to provide information concerning the neural connections to the cortex and therefore neglect the perceptual aspects of disequilibrium. At present the possibility of routine examination of these higher projections remains elusive as no practical alternatives to the expensive functional magnetic resonance imaging systems exist. However, recently a novel method of recording cortical vestibular evoked potentials (CVEPs) has been described. CVEPs utilise an existing method used to interrogate cortical projections from the auditory system in which sound waves stimulate the inner ear and the resulting electrical responses from the brain are recorded. The recent breakthrough is in the realisation that these responses also contain information from the balance organs and therefore are a direct measure of cortical processing of the vestibular inputs. Current evidence shows that CVEPs are present in the normal population and absent in patients with no vestibular function. The primary aim for this study is to extend the patient cohort to include those who have a vestibular injury but retain residual function. Patients going through standard testing will have also have CVEPs on both ears providing seminal information into the effect of injury to the peripheral vestibular system on the cortical pathways. Furthermore, by following the cohort through their complete management pathway it will be possible to ascertain if the CVEP can be used to predict rehabilitation outcome success.
Detailed Description
Ears with a vestibular deficit: Patients referred to the tertiary ear nose and throat clinics as well otoneurological clinics at the Royal Hallamshire will be eligible for enrolment. The investigators aim to record data from 36 ears with vestibular dysfunction. A) Patients will receive a consultation with an ENT Consultant or Registrar as per standard practice. B) If the patient is deemed by the doctor to have an otoneurological cause for their symptoms then further audiovestibular testing and imaging will be arranged as per standard practice. The patients will then be made aware of this study and if interested will be given the opportunity to discuss it further with the chief investigator (CI) or the principal investigator (PI). C) If agreeable the patients will be given information packs by the PI/CI and taken through the study. D) The patients will leave the consultation with the information pack and be asked to consider participation in the study. They will have no obligation to take part and they can contact the any member of the research team to ask for further information or to have any questions answered. E) Upon their return for audiovestibular testing the patients will inform the CI/PI if they wish to participate in the study and if so will have an additional test at the end of test sequence. This will add approximately 30 minutes to their appointment time. F) Patients who are suitable for rehabilitation (as per standard care pathway) will go ahead and have the course of treatment at subsequent visit(s). The outcomes following the treatment will be logged and correlated with the CVEP to check for any correlation that may or may not be present. Otologically normal ears: Normative data will be collected from 36 normal ears from subjects that have no history of audiovestibular symptoms and are not being investigated for any balance disorders. Healthy controls will be recruited via poster advertisements and potential participants asked to contact the research team if they are considering taking part.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Vestibular Neuronitis
Keywords
partial vestibular deficit, cortical vestibular evoked potential

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
51 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
vestibular deficit
Arm Type
Experimental
Arm Description
Initial clinical assessment including otoneurological examination, pure tone audiometry, tympanometry vestibular screening tests and Magnetic Resonance Imaging as clinically indicated. The cortical vestibular evoked potentials will add approximately add an extra 30 minutes to the test sequence but is minimally invasive and will not cause any pain or discomfort. It will be conducted on both the affected and non-affected ears.
Arm Title
otologically normal controll
Arm Type
Active Comparator
Arm Description
Normative data will be collected from 36 normal ears from subjects that have no history of audiovestibular symptoms and are not being investigated for any balance disorders. The cortical vestibular evoked potentials will be recorded from both ears
Intervention Type
Procedure
Intervention Name(s)
cortical vestibular evoked potentials (CVEPs)
Other Intervention Name(s)
Cortical auditory evoked potential
Intervention Description
CVEPs utilise an existing method used to interrogate cortical projections from the auditory system in which sound waves stimulate the inner ear and the resulting electrical responses from the brain are recorded (known as Cortical Auditory Evoked Potentials CAEPs)
Primary Outcome Measure Information:
Title
The degree of change of cortical vestibular evoked potential measured by amplitude (in microvolts)
Time Frame
6 months
Secondary Outcome Measure Information:
Title
The time interval between the stimulation and response (latency) of cortical vestibular evoked potential
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Vestibular deficit Group: Over 18 years of age Can provide informed consent Deemed to have an otoneurological cause for their symptoms (true vertigo, room spinning even when head is still) No middle ear pathology NORMATIVE GROUP: Over 18 years of age Can provide informed consent No previous otoneurological history Exclusion Criteria: VESTIBULAR DEFICIT GROUP PATIENTS Participants under the age of 18 Participants unable to provide informed consent Patients not deemed to have an otoneurological cause for their symptoms Patients with middle ear pathology NORMATIVE GROUP: Previous history of problems with hearing and or balance Participants under the age of 18 Participants unable to provide informed consent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jemima Clarke
Phone
+44114 226 5938
Email
Jemima.calrke@sth.nhs.uk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jaswinder S Sandhu, Dr
Organizational Affiliation
Sheffield Teaching Hospitals NHS Foundation Trust
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sheffield Teaching Hospitals NHS Trust
City
Sheffield
State/Province
South Yorkshire
ZIP/Postal Code
S10 2JF
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jemima Clarke
Phone
+441142265938
Email
jemima.clarke@sth.nhs.uk
First Name & Middle Initial & Last Name & Degree
Jaswinder S Sandhu, Dr

12. IPD Sharing Statement

Learn more about this trial

Characterisation of Cortical Vestibular Evoked Potentials (C-VEPs)

We'll reach out to this number within 24 hrs